Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Zyla Life Sciences | a2217364zs-1a.htm |
| EX-3.1 - EX-3.1 - Zyla Life Sciences | a2217364zex-3_1.htm |
| EX-3.2 - EX-3.2 - Zyla Life Sciences | a2217364zex-3_2.htm |
| EX-10.7 - EX-10.7 - Zyla Life Sciences | a2217364zex-10_7.htm |
| EX-10.3 - EX-10.3 - Zyla Life Sciences | a2217364zex-10_3.htm |
| EX-10.6 - EX-10.6 - Zyla Life Sciences | a2217364zex-10_6.htm |
| EX-10.2 - EX-10.2 - Zyla Life Sciences | a2217364zex-10_2.htm |
| EX-10.5 - EX-10.5 - Zyla Life Sciences | a2217364zex-10_5.htm |
| EX-10.1 - EX-10.1 - Zyla Life Sciences | a2217364zex-10_1.htm |
| EX-10.8 - EX-10.8 - Zyla Life Sciences | a2217364zex-10_8.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We have issued our report dated September 16, 2013, with respect to the consolidated financial statements of Egalet Limited and Subsidiary contained in the Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption "Experts."
/s/
GRANT THORNTON LLP
Philadelphia, Pennsylvania
November 14, 2013
Consent of Independent Registered Public Accounting Firm